IL6 and cancer: IL-6 signals through binding to heterodimer of IL-6R and gp130 [24, 25] and is associated with the metastatic phenotype in a range of cancers [12], and Lane et al. reported that IL-6 levels above 3 ng/ml in ascites is associated with poor prognosis in patients with ovarian cancer [10].